Family Medicine Experts & Viewpoints
- Monitoring and Managing Cardiotoxicities Associated with Cancer Therapies: An Expert Interview with Dr. Pamela S. Douglas
- Which Diet is Best? Have the Behaviorists Failed Us?
- Should Statins Ever Be Prescribed in Children With Lipid Problems?
- Why Should I Report an Adverse Drug Event?
- P-4-P? How about P-B4-P?
- Are Osteoporosis Risks Being Overlooked?
- What Is My Legal Obligation if I Allow an Intoxicated Patient to Drive Home?
- What Is the Maximum Dose of Mesalamine for Ulcerative Colitis?
- Protective Effect of Circumcision on Rates of STIs?
- ACCORD, ADVANCE, AVOID: What Do They Tell Us About Treating our Patients?
POLL
A new bill in Congress would send trained clinicians into doctors’ offices with independent data about the relative benefits, risks, and costs of drugs; some research suggests that such "academic detailing" reduces potential prescribing bias from the influence of drug company reps. What effect do you think such a program would have?